In a ruling that seems to put pomegranate juice on comparable footing with pharmaceutical drugs, the Federal Trade Commission in a final decision issued January 16 will require juice maker POM Wonderful to conduct extensive clinical trials before it can make any claims about the health benefits of its products.
FTC demands juice maker conduct trials before advertising health benefits
The National Law Journal
January 16, 2013
This article requires free registration
This article requires free registration to The National Law Journal. Please sign in or register to read the full text.